We’re excited to share our latest report on gene, cell, and RNA therapies with The American Society of Gene and Cell Therapy (ASGCT). This Q1 report calls out important updates and changes within the gene, cell, and RNA therapy landscape.
Highlights of the report include:
Approved gene, cell, and RNA therapies
Pipeline overview including
Activity including deal-making, start-up financing, noteworthy events, and upcoming catalysts for gene, cell, and RNA therapies
Shardha Specialises in
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Contact us for product technical and account support.
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: